About

Brita Belli is Head of Public Relations for Insilico Medicine. Her writing has appeared in the New York Times, National Geographic, Yale Medicine Magazine, Union of Concerned Scientists, OR Manager Magazine and European Biopharmaceutical Review. Ms Belli is the author of “The Autism Puzzle: Connecting the Dots Between Environmental Toxins and Rising Autism Rates” (Seven Stories Press) and the digital playbook “Elevating Women in Entrepreneurship” (JP Morgan Chase and InBIA).

Contributions

PHARMA INSIGHT

DEVELOPING AN INHALABLE FORMULATION OF THE FIRST GENERATIVE AI DRUG

Brita Belli introduces Insilico Medecine’s inhalable formulation of its AI-designed therapy for the treatment of idiopathic pulmonary fibrosis, its progression through clinical trials and the company’s approach to generative AI in the pharmaceutical space more broadly.